|
|
|
|
 |
| December 23,
2010 | ISSUE NUMBER 180 VOL 8 |
Global
Health Spotlight Turns to Chronic Diseases
With donor fund levels sinking, multilateral institutions are having to face an issue they have avoided for years: prioritizing time, people, and resources to tackle a few health challenges rather than many.
Regulatory
FDA’s 2011 Guidance Agenda
FDA’s annual guidance agenda serves as a blueprint—almost a wish list—for what the organization plans to focus its time and resources on in the coming year.
Forecast
Top Health Industry Issues of 2011
A new paper from PricewaterhouseCoopers forecasts change in the coming year due to health reform and other issues keeping the industry on its toes.
Biotechnology
Fixing Biotech’s Broken Business Model
Despite some notable successes, the global biotech industry has fallen short of expectations. Jo Pisani proposes some new business models for a new era.
|
|
|
 // ERT (Philadelphia) confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is Dec. 21. Dr. Joel Morganroth, currently ERT’s Chairman and Chief Scientific Officer, was elected by the Board as President and CEO until ERT hires a permanent CEO. //AstraZeneca appointed Esra Erkal Paler to head up its worldwide media relations activities. She will be based in the company’s London office and takes up her duties in April 2011. // Merck KGaA appointed Stefan Oschmann as Head of its Pharmaceuticals Division, Merck Serono (Geneva). Mr. Oschmann takes office on January 1, 2011, and will also have responsibility for the company’s consumer healthcare operations. // |
|
|
|
|
|
 |
|
 |
|
 |
| Who do you think will become the most influential healthcare stakeholders in the next few years? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
